CORONAVIRUS
LIVE UPDATES

Interview: Fears and worries of dental students during COVID-19 pandemicDwindling patient numbers leave UK clinics short of lockdown targetsDentist facing charge for putting pressure on employees to get COVID-19 vaccineEffect of COVID-19 on dental professionals in the UKResearchers scramble to understand new SARS-CoV-2 strainsCOVID-19 vaccination: Where does the dental profession stand?Californian dentists allowed to join COVID-19 vaccination effortResearchers develop tent to prevent spread of SARS-CoV-2 in dental settingsCOVID-19 causes major delays in paediatric dental care in Australia“Particularly unsafe” for COVID-19 patients—Sunstar Americas recalls mouthwash

Visit microsite

ACTEON

Products

ACTEON strives to manufacture medical devices that enable dentists to implement minimally invasive operating protocols that are less traumatic to patients.

ACTEON – Expasyl™ Exact

Expasyl™ Exact is effective and atraumatic gingival retraction paste delivered in cost effective, single use capsules that can fit in any composite application gun.

ACTEON – imaging systems

ACTEON – X-MIND TRIUM true Low Dose

ACTEON – X-Mind prime

ACTEON – X-Mind trium true low dose

TRUE LOW DOSE is the latest X-Mind trium CBCT innovation from ACTEON, with up to 50% less radiation exposure* and no loss of image quality and accuracy.

ACTEON – PURE REFLECT mirrors

ACTEON – PSPIX²

ACTEON – PRODONT (Manual Instrumentation)

ACTEON – Newtron

Exclusive and patented technology, which brings to treatments more preservation, efficacy and comfort.

1 2 Older Posts

Everything ACTEON

17 avenue Gustave Eiffel, BP 30216
MERIGNAC cedex, 33708
France
Tel.: +33 (0) 556 34 06 07
Fax: +33 (0) 556 34 92 92

www.acteongroup.com
info@acteongroup.com

NewsView All

Piezotome extractions favour bone preservation with immediate implant placement

November 02, 2020 | Events, Interviews, News

BORDEAUX, France: Tooth extraction is the most common procedure performed in oral surgery.¹ For example, ten million third molars are removed each year in the US alone, according to the American Public Health Association.² Dentists are ethically committed to using the least traumatic surgical options and least invasive techniques in order to ensure patients’ well-being, thus less traumatic extraction and implant placement are becoming the norm in today’s implant surgery.

Michael Rynerson appointed CEO of ACTEON

June 22, 2020 | Events, Interviews, News

BORDEAUX, France: Michael Rynerson is the new CEO of the dental and medical technology and device manufacturer ACTEON, which is headquartered in France. The supervisory board of Finapolline, the holding company of ACTEON, appointed him to the position effective on 1 June. The chairman of the supervisory board commented that Rynerson has over 25 years of experience, most notably in the dental industry, and possesses the skills to lead the company out of the current health and economic crisis and through its next phase of development.

EXPASYL EXACT: Effective and atraumatic gingival retraction

February 21, 2020 | Events, Interviews, News

CHICAGO, U.S.: Few products have had such a positive effect on dentistry as the EXPASYL gingival retraction paste from ACTEON. After 20 years of clinical research and efficacy, EXPASYL continues to be the choice of many dentists for tissue management during restorative and cosmetic dental treatment. Now, EXPASYL EXACT is available on the market. It offers the same results in the exact amount needed in a cost-effective, single-use capsule that can be used in any composite gun. This means that there will be no more wasted material and there is no need to purchase expensive application guns. At the 155th Chicago Dental Society Midwinter Meeting currently being held in Chicago, interested parties can view the new product at the ACTEON booth (#2811).

WebinarsView All